drugset

drugset / Trial / NCT07263230

The Safety and Efficacy of Roflumilast Foam in HS

NCT07263230 ↗

Phase 2 Recruiting 20 enrolled Beth Israel Deaconess Medical Center

NaSingle-groupOpen-labelTreatment

Summary

This study investigates the efficacy of topical roflumilast foam in patients with HS.

Timeline

Start: 2026-09-01
Primary completion: 2028-08
Completion: 2029-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Roflumilast	Small molecule	0.3 %	Topical

Indications